Pfizer, BioNTech say COVID-19 trial vaccine was 100% effective in adolescents
Pfizer, BioNTech say COVID-19 trial vaccine was 100% effective in adolescents
MarketWatch
0 shares
1 views
You might like
Related news coverage
Covid-19 Live Updates: France Will Enter Third National Lockdown
Upworthy
The Pfizer-BioNTech vaccine is highly effective in adolescents, a study suggests. No infections were recorded in children aged 12..
-
Dow's late fall into the red not enough to slow best month since November
Proactive Investors
-
Qatar- Pfizer Covid-19 vaccine safe, effective on adolescents in trial, companies say
MENAFN.com
-
Pfizer says COVID-19 vaccine safe, effective for adolescents in trial
Upworthy
-
The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents
NYTimes.com
Advertisement
More coverage
Wall Street in the green at midday following jump in jobs data; Dow teeters on the flatline
Proactive Investors
12:25pm: Traders await $2T Biden infrastructure proposal The Dow has been volatile, settling at 11 points above the flatline at..
-
Wall Street opens in the green following jump in jobs data
Proactive Investors
-
Coronavirus: Israeli adolescents to receive Pfizer vaccine if FDA approve
Upworthy
-
Pfizer/BioNTech's COVID-19 Vaccine Shows 100% Efficacy In Late-stage Trial In Adolescents
RTTNews
-
Wall Street heads for mixed open ahead of jobs data
Proactive Investors